药明康德推出 10 亿元自有资金 A 股回购用于员工持股计划。公司将持续关注市场 及业务动态，在适当时机上调指引。 投资要点： | [Table_Finance] 财务摘要(百万元) | 2024A | 2025A | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 39,241 | 45,456 | 53,969 | 62,004 | 68,944 | | (+/-)% | -2.7% | 15.8% | 18.7% | 14.9% | 11.2% | | 净利润(归母) | 9,450 | 19,151 | 19,908 | 22,087 | 23,966 | | (+/-)% | -1.6% | 102.6% | 4.0% | 10.9% | 8.5% | | 每股净收益(元) | 3.17 | 6.42 | 6.67 | 7.40 | 8.03 | | 净资产收益率(%) | 16.1% | 24.0% | 21.0% | 19.8% | 18.4% | | 市盈率(现价&最新股本摊薄) | 32.43 | ...